文献速递主动脉外科

致病性变异携带者胸主动脉夹层后主动脉进展与再干预

Aortic progression and reintervention in patients with pathogenic variants after a thoracic aortic dissection.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-02-20

本研究纳入175例胸主动脉夹层患者,其中31例携带致病性变异(致病组),144例为良性/正常变异(对照组)。致病组更年轻(43 vs 56岁,P < .0001),初始A型夹层修复时主动脉根部替换更多,但弓部替换范围相似。中位随访7.5年,致病组再干预需求显著更高(中位1 vs 0,P < .0001),保留自体主动脉根部的再干预发生率(12%/年 vs 1.2%/年,P = .0001)和9年累积发生率(70% vs 6%,P < .0001)均显著更高,而保留的主动脉弓和远端主动脉再干预两组相似,10年生存率相似(92% vs 85%)。结论建议对致病性变异携带者初始A型夹层修复时考虑积极主动脉根部替换和相似的弓部管理。

要点

  • 致病性变异携带者胸主动脉夹层后再干预风险显著高于良性/正常变异者。
  • 初始A型夹层修复时致病组更多行主动脉根部替换,但弓部替换范围相似。
  • 保留自体主动脉根部的再干预风险致病组显著更高,而弓部和远端主动脉相似。

核心结论

  • 致病性变异携带者胸主动脉夹层后主动脉再干预风险显著高于良性/正常变异携带者。
  • 建议对致病性变异携带者初始A型夹层修复时考虑积极主动脉根部替换和相似的弓部管理。

研究设计与样本

  • 回顾性队列研究,纳入175例胸主动脉夹层患者,其中31例携带致病性变异(致病组),144例为良性/正常变异(对照组)。
  • 致病性变异通过全外显子测序在6个基因(COL3A1、FBN1、LOX、PRKG1、SMAD3、TGFBR2)中鉴定。
  • 临床数据通过病历回顾(1985-2018)收集,并补充国家死亡索引数据库(2018年12月)。

主要发现

  • 致病组患者显著更年轻(43 vs 56岁,P < .0001)。
  • 初始A型夹层修复时,致病组主动脉根部替换显著更多,弓部替换范围相似。
  • 中位随访7.5(4.6-12)年,致病组再干预中位数显著更高(1 vs 0,P < .0001),10年人均累积再干预次数更高(1 vs 0.5,P = .029)。
  • 保留自体主动脉根部的再干预发生率(12%/年 vs 1.2%/年,P = .0001)和9年累积发生率(70% vs 6%,P < .0001)致病组显著更高。
  • 保留的自体主动脉弓和远端主动脉再干预两组相似,10年生存率相似(92% vs 85%)。

临床怎么用

  • 对致病性变异携带者行初始A型夹层修复时,应考虑更积极的主动脉根部替换。
  • 致病性变异携带者术后需密切监测再干预风险,尤其是保留的自体主动脉根部。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate aortic disease progression and reintervention after an initial thoracic aortic dissection in pathogenic variant carriers. METHODS: Of 175 participants diagnosed with thoracic aortic dissection, 31 had a pathogenic variant (pathogenic group) across 6 genes (COL3A1, FBN1, LOX, PRKG1, SMAD3, TGFBR2) identified by whole exome sequencing. Those with benign or normal variants (benign/normal group, n = 144) comprised the control group. Clinical data were collected through medical record review (1985-2018) and supplemented with the National Death Index database (December 2018). RESULTS: The entire cohort (n = 175) consisted of 108 type A aortic dissections and 67 type B aortic dissections, similarly distributed between groups. The pathogenic group was significantly younger (43 vs 56 years, P < .0001) and had significantly more aortic root replacements and similar extents of arch replacement at initial type A aortic dissection repair. The median follow-up time was 7.5 (4.6-12) years. After initial treatment, the pathogenic group required significantly more aortic reinterventions (median 1 vs 0, P < .0001) and mean cumulative aortic reinterventions for each patient (10 years: 1 vs 0.5, P = .029). Both incidence rate (12%/year vs 1.2%/year, P = .0001) and cumulative incidence of reinterventions (9 years: 70% vs 6%, P < .0001) for the preserved native aortic root were significantly higher in the pathogenic group, but were similar for the preserved native aortic arch and distal aorta between groups. Ten-year survival was similar in the pathogenic and benign/normal groups (92% vs 85%). CONCLUSIONS: Aggressive aortic root replacement and similar arch management should be considered in pathogenic variant carriers at initial type A aortic dissection repair compared with benign/normal variant carriers.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Norton EL, Hornsby WE, Wu X, et al. Aortic progression and reintervention in patients with pathogenic variants after a thoracic aortic dissection. J Thorac Cardiovasc Surg. 2020. PMID: 32199657. doi:10.1016/j.jtcvs.2020.01.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。